Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 8/20 | 0.63 |
| ▸ | DRD2 | P14416 | 7/20 | 0.63 |
| ▸ | DRD3 | P35462 | 7/20 | 0.63 |
| ▸ | HTR1B | P28222 | 2/20 | 0.63 |
| ▸ | HTR1D | P28221 | 1/20 | 0.63 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938905 | 0.81 | DRD4 (0.91) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL10476759 | 0.79 | DRD4 (0.95) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL11410999 | 0.78 | DRD4 (0.70) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL11402571 | 0.77 | DRD4 (0.63) | DRD4DRD2DRD3HTR1BHTR1D | |
| Hydrochloric Acid SCHEMBL8054973 | 0.77 | DRD4 (0.91) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL11896615 | 0.77 | DRD4 (1.00) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL28693297 | 0.77 | DRD4 (0.63) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL595753 | 0.77 | HTR1B (1.00) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL1488231 | 0.77 | DRD4 (0.63) | DRD4DRD2DRD3HTR1BHTR1D | |
| SCHEMBL4867980 | 0.77 | DRD4 (0.63) | DRD4DRD2DRD3HTR1BHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3319139-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR BATTERY, AND COMPOSITION | Fujifilm Corporation (JP) | 2018-05-09 | — | — | EP | disclosed |
| US-20180108492-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION | FUJIFILM CORPORATION (JP) | 2018-04-19 | — | — | US | disclosed |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | IPSEN PHARMA S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108492-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION | SCNN1A, CRY1, NR2E3 | DRD4 1256/4885DRD2 2278/4885DRD3 2179/4885 |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | SSTR2, SSTR5, SSTR3 | DRD4 406/4885DRD2 324/4885DRD3 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.